Back to search

Netherlands· NL-6ea44feb5ba0

A. Vogel Aesculaforce tabletten

A hippocastani semen product containing aesculus hippocastanum semen ethanol-water (60-40) droog extract, der (7,1-11,2 = 1), registered in Netherlands by A.Vogel B.V.. The same ATC class is registered in 7 of our 19 countries.

ATC C05CX03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedA. Vogel Aesculaforce tablettenATCC05CX03REGISTER NO.NL-6ea44feb5ba0PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Hippocastani semen is registered in 7 of 19 countries.

Countries holding a registration under ATC C05CX03 (hippocastani semen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose

Hippocastani semen · ATC C05CX03

7 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
AESCULUS HIPPOCASTANUM SEMEN ETHANOL-WATER (60-40) DROOG EXTRACT, DER (7,1-11,2 = 1)
Manufacturer
A.Vogel B.V.
Country
Netherlands (NL)
ATC code
C05CX03
ATC class
Hippocastani semen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    100864

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Hippocastani semen in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hippocastani semen products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Germany · Venen-Aktiv
  • Italy · Flebostasin R
  • Poland · Esceven, Hiposem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/81b8668d-18fb-47d3-a649-7150c1e5fff9
GET /v1/drugs/81b8668d-18fb-47d3-a649-7150c1e5fff9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h100864_smpc.pdf",
  "strength": null,
  "atc_label": "Hippocastani semen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg100864",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1)",
    "COPOVIDON (E 1208)",
    "MAÏSZETMEEL",
    "POLYSACCHARIDEN VAN SOJA",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TRIETHYLCITRAAT (E 1505)"
  ],
  "substances": [
    "AESCULUS HIPPOCASTANUM SEMEN ETHANOL-WATER (60-40) DROOG EXTRACT, DER (7,1-11,2 = 1)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h100864.pdf",
  "authorised_at": "2009/09/10",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "100864",
  "additional_monitoring": "N"
}

See everything about hippocastani semen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.